Twelve finalists were selected from 57 applicants. Equalize 2020 will run two, parallel pitch sessions: Diagnostics & Medical Devices and Therapeutics.
Diagnostics & Medical Devices Session
Reetuparna Das
University of Michigan
Startup: Sequal
Technology:Ultra-rapid molecular diagnosis of cancer
Melanie Joy
University of Colorado
Startup: Katharos, Inc.
Technology: Extracorporeal device for optimizing
phosphate control in hemodialysis
Sunyoung Kim
Louisiana State University School of Medicine & Health Sciences Center
Startup: Chosen Diagnostics Inc.
Technology: Biomarker panel to improve
necrotizing enterocolitis diagnosis
Kacey Marra
University of Pittsburgh
Startup: AxoMax Technologies, Inc.
Technology: Biodegradable nerve guide
Sarah Vigmostad
The University of Iowa
Startup: SynderBio, Inc.
Technology: Novel, high-throughput cell separation
techniques for single cell sequencing and cancer diagnosis
Pamela Woodard
Washington University in St. Louis
Startup: GwynTech
Technology: AtheroBrite
Therapeutics Session
Alexis Demonbreun
Northwestern University
Startup: Ikaika Therapeutics
Technology: Genetic modifiers of muscle disease
as therapeutic targets
Barbara Ehrlich
Yale University
Startup: Center Pharm
Technology: A new target for treatment of
Wolfram Syndrome
Yiping Han
Columbia University
Technology: Novel therapeutics to treat
familial adenomatous polyposis (FAP)
Sandhya Kortagere
Drexel University
Technology: A disease modifying and neuroprotective
agent to treat Parkinson’s disease
Martina Roos
University of California, Los Angeles
Startup: Sardona Therapeutics
Technology: Small molecules targeting RNA regulators in cancer stem cells
Judith Sebolt-Leopold
University of Michigan
Startup: Mekanistic Therapeutics
Technology: A first-in-class therapeutic targeting
deregulation of EGFR and PI3K